Stock listing

NASDAQ:RACB Research Alliance Corp II Stock

Follow Research Alliance Corp II into a list and get an email when it puts out news.

Last close · NASDAQ:RACB

$10.11 USD

Close on Dec 15, 2022 · No longer trades

Mar 18, 2021 to last close -1.0% · weekly closes, Mar 18, 2021 – Dec 15, 2022
Lowest – highest close
$9.66 – $11.29 USDSince Mar 18, 2021 · lowest Jan 24, 2022 · highest Apr 14, 2021

Delisted NASDAQ:RACB no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:RACB
Asset type
Stock
Exchange
NASDAQ
Currency
USD

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Matthew Hammond
Other companies: Research Alliance Corporation IV (Chief Executive Officer, Director · Since at least Jul 10, 2026); Research Alliance Corporation III (Chief Executive Officer, Director · Since at least May 19, 2026); POINT Biopharma Global Inc (Chief Financial Officer, Director · Jul 7, 2020 – Jul 7, 2020 · Past)
Chief Investment Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past
Thomas Leggett
Other companies: Stoke Therapeutics, Inc. (Chief Financial Officer · Since at least May 7, 2024); Black Diamond Therapeutics, Inc. (Chief Financial Officer · Jan 29, 2020 – Feb 17, 2021 · Past); Axcella Health Inc (SVP Finance, CFO · May 8, 2019 – May 8, 2019 · Past)
Director · Mar 17, 2021 – Mar 17, 2021 · Past
Theresa Cameron
Other companies: Cytek Biosciences, Inc. (Director · Jul 22, 2021 – Jul 22, 2021 · Past)
Chief Financial Officer, Director · Mar 17, 2021 – Mar 17, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Research Alliance Corp II.